215 related articles for article (PubMed ID: 11572580)
1. Personal experience in advanced pancreatic cancer: retrospective analysis on the use of 5-fluorouracil or gemcitabine.
Martinelli B; Pigni A; Fagnoni E; Chini C; Vallini I; Pinotti G
Dig Liver Dis; 2001; 33(6):503. PubMed ID: 11572580
[No Abstract] [Full Text] [Related]
2. Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer.
Klein B; Sadikov E; Mishaeli M; Levin I; Figer A
Oncol Rep; 2000; 7(4):875-7. PubMed ID: 10854561
[TBL] [Abstract][Full Text] [Related]
3. In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.
Crane CH
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1009; author reply 1009-10. PubMed ID: 14967465
[No Abstract] [Full Text] [Related]
4. Clinical benefit as a primary efficacy endpoint.
Ballatori E; Del Favero A; Roila F
J Clin Oncol; 1998 Feb; 16(2):803-4. PubMed ID: 9469377
[No Abstract] [Full Text] [Related]
5. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
6. Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.
Kizilbash SH; Ward KC; Liang JJ; Jaiyesimi I; Lipscomb J
Int J Clin Pract; 2014 May; 68(5):578-89. PubMed ID: 24472057
[TBL] [Abstract][Full Text] [Related]
7. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.
Ward S; Morris E; Bansback N; Calvert N; Crellin A; Forman D; Larvin M; Radstone D
Health Technol Assess; 2001; 5(24):1-70. PubMed ID: 11701098
[No Abstract] [Full Text] [Related]
8. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.
Oztop I; Yilmaz U; Yavuzsen T; Yaren A; Tarhan O; Sagol O; Coker A; Alakavuklar M
Chemotherapy; 2004 Jun; 50(3):127-32. PubMed ID: 15282439
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.
Park JK; Ryu JK; Lee JK; Yoon WJ; Lee SH; Kim YT; Yoon YB
Pancreas; 2006 Nov; 33(4):397-402. PubMed ID: 17079946
[TBL] [Abstract][Full Text] [Related]
10. Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma.
Hong GB; Zhou JX; Sun HB; Li CY; Song LQ
Asian Pac J Cancer Prev; 2012; 13(6):2669-73. PubMed ID: 22938439
[TBL] [Abstract][Full Text] [Related]
11. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris HA; Moore MJ; Andersen J; Green MR; Rothenberg ML; Modiano MR; Cripps MC; Portenoy RK; Storniolo AM; Tarassoff P; Nelson R; Dorr FA; Stephens CD; Von Hoff DD
J Clin Oncol; 1997 Jun; 15(6):2403-13. PubMed ID: 9196156
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine for pancreatic cancer: a step in the right direction.
Ko AH; Tempero MA
Gastroenterology; 2009 Jan; 136(1):43-5. PubMed ID: 19041649
[No Abstract] [Full Text] [Related]
13. Pancreatic cancer.
Clin Evid; 2003 Jun; (9):528-33. PubMed ID: 12967377
[No Abstract] [Full Text] [Related]
14. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review].
Bjerregaard JK; Pfeiffer P
Ugeskr Laeger; 2007 Nov; 169(46):3949-52. PubMed ID: 18078646
[No Abstract] [Full Text] [Related]
16. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
Ishii H; Furuse J; Boku N; Okusaka T; Ikeda M; Ohkawa S; Fukutomi A; Hamamoto Y; Nakamura K; Fukuda H;
Jpn J Clin Oncol; 2010 Jun; 40(6):573-9. PubMed ID: 20185458
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
Prescrire Int; 1999 Jun; 8(41):74-5. PubMed ID: 10558444
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine in carcinoma of the pancreas.
Smith DB; Neoptolemos JP
Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
20. What options are available for refractory pancreatic cancer?
Choi M; Kim R; Saif MW
JOP; 2012 Mar; 13(2):163-5. PubMed ID: 22406591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]